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Neglected tropical diseases (NTDs) are a diverse group of infectious conditions that vary in their epidemiology,
impact and control. They are among the most common conditions globally, affecting approximately one bil-
lion people. Many NTDs have long-term consequences, such as visual and physical impairments. As a result,
people with NTDs may have difﬁculties in carrying out activities or participating in society—in other words,
NTDs can cause disabilities. Additionally, NTDs are often strongly linked to stigma and can have mental health
consequences. It is therefore important to incorporate rehabilitation within NTD programmes. Rehabilitation
can be conceptualized narrowly in terms of the provision of clinical services (e.g. physiotherapy and assistive
devices) or, more broadly, including efforts to improve employment, overcome stigma and enhance social par-
ticipation of people with disabilities. Approximately 15% of the global population has a disability, and this
large group must be considered when designing NTD programmes. Improving the inclusion of people with dis-
abilities may require adaptations to NTD programmes, such as making them physically accessible or training
staff about disability awareness. Without incorporating disability within NTD programmes, the quality of life of
people with NTDs will suffer and global targets for elimination and management of NTDs will not be met.
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Introduction
Neglected tropical diseases (NTDs) are a diverse group of infec-
tious conditions that vary in their distribution, epidemiology,
impact and control. Collectively they are among the most com-
mon diseases globally,1 with the World Health Organization
(WHO) estimating that one billion people are affected by NTDs.
NTDs share common features: they are treatable or preventable
through relatively simple public health interventions and are
concentrated in the poorest countries and among the poorest
people. Moreover, they are neglected, meaning that they are
reported late and diagnosed and treated late, so NTDs often
lead to chronic conditions, although rarely to death. This feature
distinguishes NTDs from other high-proﬁle infectious diseases,
such as human immunodeﬁciency virus, malaria and tubercu-
losis, which are often fatal. Essentially NTDs are common, avoid-
able and potentially debilitating, which is why prioritizing their
control is important. As a result, the last decade has witnessed
an extraordinary increase in the attention given to NTDs, includ-
ing an initiative by the WHO for the control, elimination and
eradication of 17 NTDs by 2020.2
There are many overlaps and similarities between NTDs and
disability. Like NTDs, disability affects about one billion people
and is concentrated among the poorest in the world.3 Disability
is also receiving growing international attention, with a high-
proﬁle Global Disability Summit arranged by the UK government
and convened in London on 24 July 2018 to draw attention to
this global issue. The aim of this review is to reﬂect on the con-
nections between disability and NTDs. The review will put NTDs
explicitly within a disability framework to consider which strat-
egies could or should be put in place for NTD control to more
holistically meet the needs of patients. It will also discuss the
adaptation of NTD control programmes to be inclusive of people
with disabilities and what the potential gains are of taking this
approach. A formal systematic review was not undertaken, due
to the lack of speciﬁcity of the search terms for NTDs and dis-
abilities, thus a scoping review of the relevant literature was
conducted.
What is disability and why is it important?
There are many different ways of conceptualizing disability. The
most common way of describing disability is through the
International Classiﬁcation of Functioning, Disability and Health
(ICF) model of the WHO (Figure 1).4
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Essentially, a health condition can lead to an abnormality in
body functions and structures. For instance, repeated infection
with Chlamydia trachomatis can, over time, cause trichiasis,
where the eyelid rotates and the eyelashes scratch against the
eye. Trichiasis can lead to corneal ulceration and ultimately to
corneal opacity and blindness. In this example, trachoma infec-
tion is the health condition and blindness is the abnormality in
body function and structure, that is, the impairment. People who
are blind can experience difﬁculties in performing activities, such
as walking independently. These activity limitations can cause
participation restrictions, such as difﬁculties in working or joining
in social events. As a consequence, people with disabilities are
being left behind, including in terms of schooling, and employ-
ment, and they are more likely to be poor.3 The impact of blind-
ness on participation restriction and exclusion is not the same for
everyone, but is inﬂuenced by personal and environmental fac-
tors. For instance, people with positive personal factors, such as
high levels of social support or personal wealth, may be enabled
to participate in events despite their blindness. Similarly, the pro-
vision of mobility devices (e.g. white canes) and an accessible
physical environment, will help people to engage in activities.
Using this framework, it is clear that most of the NTDs can
cause impairments. As examples, Buruli ulcer starts with a skin
infection that can lead to extensive tissue necrosis and ultim-
ately potentially to damage to the eye and amputation and
contracture at the knee and ankle joints. Guinea worm infection
is initially symptom free, but about 1 y later can cause painful
blistering of the skin, vomiting and dizziness, with consequent
difﬁculties in walking. A study of 982 people infected with
Guinea worm in Nigeria found that 21% were ‘totally incapaci-
tated’, 20% were ‘seriously disabled’, 44% had ‘mild incapacity’
and only 16% were unaffected.5 Overall, most of the 17 main
NTDs can lead directly to impairments: trachoma and onchocer-
ciasis can cause blindness, while leprosy, chikungunya, yaws,
lymphatic ﬁlariasis, Buruli ulcer, Chagas disease and African
trypanosomiasis can lead to physical impairments. NTDs can
also cause impairments indirectly. Soil-transmitted helminths
and schistosomiasis in childhood can lead to delayed physical
and mental development and a predisposition to developmental
disabilities. NTDs are also linked to mental health conditions,
particularly depression, whether through the direct effects of
disease (e.g. neurological sequelae) or as a result of the pain,
discomfort and stigma experienced.6
There are many examples of how NTD-related impairments
can lead to activity limitations and participation restriction and
thus negatively impact on well-being. Schistosomiasis infection
may cause abdominal pain, diarrhoea and blood in the stool or
urine. In children, it is also linked to poorer learning and mem-
ory, as well as lower school attendance and achievement,7,8
which may impact on well-being. For instance, a survey of
adults in Cote D’Ivoire showed lower quality of life associated
with schistosomiasis infection.9 Sleeping sickness causes pain,
amnesia and physical impairments, and a Zambian study
showed that infection was linked to loss of productive time,
dropping out of school, loss of friends and lower self-esteem.10
Lymphatic ﬁlariasis infection can cause lymphedema (swelling
in body tissue), scrotal hydrocele (swelling in the scrotum) and
rheumatic and respiratory problems. These symptoms can result
in difﬁculties walking, with the added effect of reduced eco-
nomic productivity.11,12 For instance, a study in Malawi showed
that people with lymphatic ﬁlariasis earned less than half the
amount of unaffected controls per week (cases, $0.70; controls,
$1.86) but spent more money on health care (16% vs 22%).13
People with NTDs also often face stigmatizing attitudes and
social exclusion,14 and this is often a key concern for those
affected. Perhaps the clearest example of stigma is for leprosy.15
Leprosy can cause damage to the eyes, hands and feet, with
consequent difﬁculties in social and economic participation.16
Additionally, stigma is repeatedly shown to be pronounced
among people living with leprosy,17,18 perhaps because it causes
visible symptoms and there is a great fear of contagion. The
Stigma Assessment and Reduction of Impact (SARI) study in
Indonesia collected quantitative data and undertook in-depth
qualitative interviews (n=49).16 The study showed that 36% of
people living with leprosy experienced stigma, speciﬁcally related
to problems in marriage, difﬁculties in employment and shame.
These quantitative ﬁndings are supported by evidence from the
in-depth interviews, as described by one source from Indonesia:
‘If he is badly affected and people know that he is affected
by leprosy, he will not have any friends’.19
While another stated:
‘People who are affected by leprosy should be banished to
the forest [laughs]. They should not live together with other
people in the village. Their houses should also be burnt.
That was what my parents told me’.
This stigma is so widespread that the term ‘leper’ alone is an
insult in many languages, and the expression of feeling ‘like a
leper’ is a synonym for social exclusion. Stigma and discrimin-
ation is also a common experience for people with other NTDs,
for instance, lymphatic ﬁlariasis. Symptoms of this condition
may be distressing and stigmatizing, with several studies linking
it to depression and anxiety12,20,21 and marital and sexual pro-
blems.11,22 A study in India found that hydrocele patients were
viewed as the ‘last choice’ of a partner to marry.22 Stigma in
relation to NTDs is described well by a woman in Uganda
reﬂecting about the lives of people with skin conditions, result-
ing from onchocerciasis:
Figure 1. International Classiﬁcation of Functioning, Disability and
Health (ICF) model.
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‘They are hiding their skin so that people cannot see them.
I have not heard of anyone who wants others to know
about it. No one will allow them to lead, and many people
ignore them. They are considered dangerous. People fear
contact with them. I feel sorry for them. Even me, I feared
that from staying and meeting them we could get the dis-
ease… They ﬁnd it hard to marry, and marriages can break
because of this condition’.15
Stigma related to disabilities and its impacts may vary between
men and women. One study on leprosy conducted in Nepal,
Indonesia, Nigeria and Brazil found that stigma resulted in more
delayed care-seeking in men than in women.23 Moreover,
affected men were more concerned about losing their jobs or
social status in the community, while affected women worried
more about the impact on their domestic roles (e.g. relationship
with mother-in-law). Despite these tantalizing ﬁndings, data
addressing gender differences in stigma resulting from NTD-
related disabilities is sparse and does not always show strong
gender differences. For instance, a study from Bangladesh
showed high levels of stigma among people with leprosy and
demonstrated that this impacted negatively on quality of life, but
it did not identify clear gender differences in these associations.24
Incorporation of rehabilitation in NTD
programmes
The previous section highlighted that NTDs are potentially disab-
ling, with implications in terms of reduced economic productiv-
ity, poorer quality of life, social exclusion, negative mental
health impacts and high levels of stigma. These impacts are not
surprising to NTD researchers and they may question why it is
useful to place NTDs within a disability framework. The main
reason is to allow us to think in a more structured way about
the disabling impacts of NTDs and how they can be alleviated,
using the ICF model as a guide.
As an example, a large study was conducted to assess the
impact of trichiasis in Ethiopia.25–28 A total of 1000 adults with
trichiasis and 200 comparison subjects were recruited and all
patients received free trichiasis surgery. The impact of trichiasis in
the lives of people was pronounced. At baseline, people with
trichiasis were signiﬁcantly poorer, participated less in economic
activities, experienced more difﬁculties in undertaking activities
and needed more assistance as compared with controls without
trichiasis.25 Trichiasis was also strongly linked to reduced vision-
related and health-related quality of life, even in the absence of
visual impairment.26 These data show that trichiasis itself is dis-
abling, even when vision is unaffected. After trichiasis surgery,
people reported improved participation in economic activities
(e.g. farming, fetching wood), being able to perform activities
without assistance (e.g. animal rearing, farming)27 and better
quality of life.28 These changes were mostly independent of
improvements in visual acuity and were likely driven at least in
part by the alleviation of ocular pain resulting from the surgery
(ocular pain was experienced by 99% of cases at baseline and
34% after surgery). In other words, trichiasis surgery can help to
alleviate disability. Putting an NTD program within a disability
framework thus provides additional rationale for investing in NTD
treatment, as the programme can alleviate disability as well as
prevent speciﬁc health conditions or impairments. In the example
of trichiasis, surgery does not just prevent blindness, but also can
improve quality of life. This is also true for other NTDs; for
instance, ivermectin treatment reduces the risk of blindness, but
also alleviates symptoms of extreme itchiness among people
with onchocerciasis and thus improves well-being.
Another reason why the ICF disability framework is important
is because many NTD-related impairments cannot be avoided
and there are already millions of people living with disabilities
related to NTDs around the world. Turning to the ICF framework,
strengthening ‘personal’ and ‘environmental’ factors can help to
improve activities and participation, even when the impairment
cannot be reduced. In other words, rehabilitation may help to
alleviate disability in people with untreatable impairments. The
WHO deﬁnes rehabilitation as ‘a set of measures that assist
individuals, who experience or are likely to experience disability,
to achieve and maintain optimum functioning in interaction
with their environment.’3 Rehabilitation can be conceptualized
narrowly from a clinical perspective, with a focus on services
such as physiotherapy, speech and language therapy, psycho-
logical support and provision of orthoses, prostheses and assist-
ive devices. Rehabilitation can also be thought of more broadly,
including initiatives to overcome stigma and discrimination,
improve participation (e.g. in education, employment, social life)
and provide social assistance. In either case, the focus of
rehabilitation is to improve the functioning of people with dis-
abilities by addressing personal (e.g. wealth, training) and envir-
onmental factors (e.g. assistive technologies) and thereby
improve their activities, participation and quality of life.
A clear recommendation for NTD programmes is therefore
that they should link people with NTD-related impairments to
clinical rehabilitation services, as these links are currently often
lacking. For instance, an overview of existing programmes for
lymphatic ﬁlariasis found that only 26 of 81 endemic countries
had morbidity programmes in place at all.29 Additionally, pro-
grams may consider screening people more regularly for impair-
ments to identify need. Clinical tools, such as to assess the
presence of hearing, visual or physical impairments, are broadly
available to routinely screen NTD clients,30 including using
smartphone tools (e.g. Peek Vision and hearScreen).
Management of physical symptoms alone is insufﬁcient,
however, as not all symptoms can be cured, and a major impact
of NTDs is in creating stigma, and thereby discrimination. Some
NTD programmes, in particular leprosy programmes, have made
attempts to implement strategies to reduce stigma,31 often
relying on raising awareness about a condition to take away the
fear and ignorance, and thus reduce stigma. The SARI trial in
Indonesia showed that increasing ‘contact events’ between
people with and without leprosy, such as through giving testi-
monies, developing participatory videos or comics, improved
knowledge about leprosy in the general population and reduced
negative attitudes.19 Qualitative interviews undertaken as part
of the trial also supported the beneﬁts of the intervention. As
one community member said,
‘This [contact event] is very good, I understand more. I
used to be very afraid to visit someone who has leprosy,
but now I am not afraid’.
Transactions of the Royal Society of Tropical Medicine and Hygiene
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A study in Nepal showed that women living with leprosy
reported high levels of problems in their marital and sexual rela-
tionships, including due to fear of leprosy, and thus advocated
for education and counselling at the point of diagnosis in order
to reduce stigma.18 Anecdotally, in Brazil, parents of children
with disabilities related to Zika report experiencing less stigma
and more social support than parents of children with other dis-
abilities (e.g. cerebral palsy), presumably because of the high
levels of knowledge and awareness about Zika within the gen-
eral population. NTD programmes should therefore consider
implementing speciﬁc strategies to raise awareness about the
condition and thereby reduce stigma. NTD programmes may
also consider strengthening links with mental health services to
enhance the well-being of service users.
Some NTD programmes have gone further still and have incor-
porated more holistic rehabilitation into their control strategy.
Onchocerciasis was extremely widespread and a major cause of
blindness in Africa before the implementation of the successful
African Programme for Onchocerciasis Control. Onchocerciasis is
highly clustered geographically and is most common close to rivers
(which was why it was called ‘river blindness’), where the land is
also the most fertile. Eventually, in some communities, large pro-
portions of the adults became blind and communities began to
abandon the most fertile lands available. As a result, Agricultural
Rehabilitation of the Blind (ARB) was established for men blinded
by onchocerciasis in Ghana and Burkina Faso in the 1970s.
Activities included training people in mobility, agricultural and han-
dicraft techniques at residential courses and in the people’s home
villages. Over time these programmes became the basis from
which community-based rehabilitation (CBR) was developed by the
WHO in the 1980s. CBR has a broader scope than the original ARB
programmes and tries to address the holistic needs of people with
disabilities in terms of health, education, livelihood, social inclusion
and empowerment through the development of community-
based and community-led projects.32 As an example of a CBR pro-
gramme for NTDs, Lepra, a leprosy focused charity, offers pro-
grammes that focus on both the diagnosis and treatment of
leprosy, but also on tackling stigma and discrimination and provid-
ing means to improve livelihoods.
Currently, integration of rehabilitation within NTD programmes
is lacking, for several reasons. The focus on NTD programmes is
mostly to prevent and treat, in the belief that if these are effect-
ive, then rehabilitation will not be needed. However, not all cases
of NTDs can be avoided, and many people are already disabled
as a result of NTDs. Another constraint is that disability and mor-
bidity have not been measured routinely in NTD programmes,
and as the adage goes, ‘what isn’t counted doesn’t count’. The
lack of data hampers advocacy, as well as planning for interven-
tions, monitoring and evaluating the impact of programmes and
identifying funding.33 Different tools are available to collect data
on disability in NTD programmes. For instance, the WHO Disability
Assessment Schedule (WHODAS), WHO Quality of Life (WHOQOL)
and Participation Scale (P-scale) have been used to measure
quantitatively the impact of NTDs (and NTD programmes) on
quality of life, activities and participation. It is also important to
use qualitative tools to capture the broader impact of NTDs
through people’s own stories and experiences, as well as to
understand barriers to uptake or effectiveness of services.
Consensus is needed on which tools should be used in order to
scale up comparable data collection.33 Finally, there is a lack of
rigorous evidence of what works to alleviate disability among
people with NTDs. As one example, a systematic review identiﬁed
only three studies that assessed the cost-effectiveness of inter-
ventions to improve functioning in people with leprosy, and these
studies were generally small and of poor quality.34 The literature
for other NTDs is likely to be poorer still. A clear recommendation
is that more research is needed on the disabling impacts of NTDs
and how these can be overcome in order to support the expan-
sion of NTD programmes to incorporate rehabilitation.
Consideration of people with disabilities when
designing NTD programmes
People with disabilities make up 15% of the global population.3 On
average, therefore, one in seven people targeted by NTD pro-
grammes will have disabilities. This proportion could be higher still,
as both NTDs and disability are more common among the poorest
sectors of society. The upshot is that consideration needs to be
given to the inclusion of people with disabilities in mass drug
administration and other NTD control programmes. If people with
disabilities are not included in programmes, then the global targets
for elimination and management of NTDs will not be met.
People with disabilities can face a range of barriers to taking
part in NTD programmes. They are not a homogeneous group
and include people varying by impairment type, age, gender, reli-
gion, and so on, and so the exact barriers faced will vary for dif-
ferent people and in different settings. However, broadly
speaking, common barriers facing people with disabilities to
inclusion in NTD programmes are physical inaccessibility, com-
munication barriers, stigmatizing attitudes and discrimination,
ﬁnancial constraints and lack of knowledge of health care pro-
fessionals. Therefore NTD programmes need to identify the most
common barriers and put in place mechanisms to overcome
these barriers. For instance, programmes may have to tackle
physical barriers (e.g. ensuring treatment distribution points are
accessible), provide communications in a range of formats (e.g.
visual, radio) and include images of people with disabilities in
campaign pictures to highlight that the programme is for every-
one. These changes will make NTD programmes more accessible
to people with disabilities, but will also improve inclusion for
other people, such as older people, minority language speakers
and people with short-term health conditions, and so improve
the overall reach of NTD programmes. People with disabilities
must be included in the planning, and potentially the delivery, of
NTD programmes, to ensure that the key barriers are identiﬁed
and appropriately addressed.
Monitoring inclusion is important to check whether these
efforts are working. Sightsavers has monitored whether people
with disabilities are included in their trichiasis camps within its
trachoma programme in Tanzania, using a standardized
approach to assessing disability (the Washington Group Short
Set35).36 They found that approximately 14% of people under-
going trichiasis surgery had a disability (i.e. reported a lot of dif-
ﬁculty or more in at least one of six domains). This proportion
was comparable to the prevalence of disability in a large survey
in the general population in Tanzania with similar age groups,
indicating that the trichiasis service was inclusive of people with
H. Kuper
4 of 6
D
ow
nloaded from
 https://academ
ic.oup.com
/trstm
h/advance-article-abstract/doi/10.1093/trstm
h/trz001/5406189 by London School of H
ygiene & Tropical M
edicine user on 20 June 2019
disabilities. The data also helped programme managers consider
what other services may be needed for their clients. As the
regional NTD coordinator in Tanzania said,
‘We provide eye services but a client could have other
issues while for us [previously] we prioritized eyes. We never
realized that behind the scene this person has other pro-
blems. Knowing the results and getting data about disabil-
ity has opened our mind on health provision’.
‘The data can be used to improve eye services to the camps
… Data can be triangulated and other services provided’.
The Department for International Development and other inter-
national agencies are now advocating for the collection of data
on disability in programmes to ensure that they are inclusive,
and this is also encouraged within the Sustainable Development
Goals. More case studies are needed on how this data collection
should be achieved. We also need more evidence on what the
common barriers are facing people with disabilities in inclusion
in NTD programmes and how these may best be overcome.
Conclusions
Many NTDs are potentially disabling. It is therefore important to
expand the focus of NTD programmes to incorporate rehabilita-
tion, as this will help improve the quality of life of people living
with NTDs. People with disabilities make up 15% of the global
population and thus a priority for NTD programmes is to ensure
that they are inclusive of people with disabilities so that a great-
er proportion of the population is reached and NTD targets are
more likely to be met. Harnessing the current momentum
behind both disability and NTDs will make both sectors stronger
and help make sure that no one is left behind as we move
towards NTD control.
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